As part of the Leadership team at ClearView Healthcare Partners, Dean has over 15 years’ commercial and research experience in biotechnology, pharmaceuticals and medical devices. He has worked extensively with senior management teams at companies in Europe, North America and Asia to build successful corporate, commercial and R&D strategies and capabilities.
Dean has broad experience supporting companies develop asset, portfolio and corporate strategies, ranging from therapeutic area growth strategy to gene therapy platform development and transactional support. In addition, he brings extensive experience across the global commercial landscape for therapeutics, diagnostics and digital technologies.
Prior to joining ClearView, Dean worked in life sciences consulting for over 10 years following academic research in stem cell biology, epigenetics, transcriptional regulation and cancer.
Dean received his PhD in Stem Cell Biology from the University of Edinburgh and BSc (Hons) in Molecular Genetics from King’s College London.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson